This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2011 Jan 1;377(9759):8-9.

doi: 10.1016/S0140-6736(10)61885-5.

Pathogenic C difficile is here (and everywhere) to stay

Cirle A Warren¹, Richard L Guerrant

Affiliations

PMID: 21084110
DOI: 10.1016/S0140-6736(10)61885-5

Comment

Pathogenic C difficile is here (and everywhere) to stay

Cirle A Warren et al. Lancet. 2011.

. 2011 Jan 1;377(9759):8-9.

doi: 10.1016/S0140-6736(10)61885-5.

Authors

Cirle A Warren¹, Richard L Guerrant

Affiliation

¹ Center for International Health, Division of Infectious Diseases, University of Virginia, Charlottesville, VA 22908, USA.

PMID: 21084110
DOI: 10.1016/S0140-6736(10)61885-5

No abstract available

PubMed Disclaimer

Comment on

Clostridium difficile infection in Europe: a hospital-based survey.
Bauer MP, Notermans DW, van Benthem BH, Brazier JS, Wilcox MH, Rupnik M, Monnet DL, van Dissel JT, Kuijper EJ; ECDIS Study Group. Bauer MP, et al. Lancet. 2011 Jan 1;377(9759):63-73. doi: 10.1016/S0140-6736(10)61266-4. Lancet. 2011. PMID: 21084111

Similar articles

Clostridium difficile diarrhea.
Williams CN. Williams CN. Can J Gastroenterol. 1999 May;13(4):293-4. Can J Gastroenterol. 1999. PMID: 10360986 Review. No abstract available.
Clostridium difficile healthcare-associated epidemics.
Rasko DA. Rasko DA. Nat Genet. 2013 Jan;45(1):6-7. doi: 10.1038/ng.2499. Nat Genet. 2013. PMID: 23268129 No abstract available.
Does PPI therapy predispose to Clostridium difficile infection?
Pant C, Madonia P, Minocha A. Pant C, et al. Nat Rev Gastroenterol Hepatol. 2009 Sep;6(9):555-7. doi: 10.1038/nrgastro.2009.128. Nat Rev Gastroenterol Hepatol. 2009. PMID: 19713988
Clostridium difficile infection: new developments in epidemiology and pathogenesis.
Rupnik M, Wilcox MH, Gerding DN. Rupnik M, et al. Nat Rev Microbiol. 2009 Jul;7(7):526-36. doi: 10.1038/nrmicro2164. Nat Rev Microbiol. 2009. PMID: 19528959 Review.
Hidradenitis suppurativa and risk for development of Clostridium difficile colitis.
Lyons AB, Kaddurah H, Peacock A, Zubair R, Vellaichamy G, Norwick P, Ramesh M, Jacobsen G, Hamzavi IH. Lyons AB, et al. Int J Dermatol. 2020 Jun;59(6):e218-e219. doi: 10.1111/ijd.14787. Epub 2020 Feb 3. Int J Dermatol. 2020. PMID: 32010962 No abstract available.

See all similar articles

Cited by

Individual-specific changes in the human gut microbiota after challenge with enterotoxigenic Escherichia coli and subsequent ciprofloxacin treatment.
Pop M, Paulson JN, Chakraborty S, Astrovskaya I, Lindsay BR, Li S, Bravo HC, Harro C, Parkhill J, Walker AW, Walker RI, Sack DA, Stine OC. Pop M, et al. BMC Genomics. 2016 Jun 8;17:440. doi: 10.1186/s12864-016-2777-0. BMC Genomics. 2016. PMID: 27277524 Free PMC article.
Complete Genome Sequence of the Hypervirulent Bacterium Clostridium difficile Strain G46, Ribotype 027.
Gaulton T, Misra R, Rose G, Baybayan P, Hall R, Freeman J, Turton J, Picton S, Korlach J, Gharbia S, Shah H. Gaulton T, et al. Genome Announc. 2015 Mar 26;3(2):e00073-15. doi: 10.1128/genomeA.00073-15. Genome Announc. 2015. PMID: 25814591 Free PMC article.
Clostridium Difficile Colitis in Trauma Patients - a Global Step by Step Review.
Morteanu S, Chirt G, Beuran M. Morteanu S, et al. Maedica (Bucur). 2015 Jun;10(2):163-169. Maedica (Bucur). 2015. PMID: 28275412 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

Grants and funding

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information